BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 8195834)

  • 1. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antimicrobial activity of diethyldithiocarbamate and dimethyldithiocarbamate against methicillin-resistant Staphylococcus.
    Taylor EH; Walker EM; Bartelt M; Day S; Pappas AA
    Ann Clin Lab Sci; 1987; 17(3):171-7. PubMed ID: 3037985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological conclusions.
    Jones RN
    Drugs; 1991; 42 Suppl 3():22-4. PubMed ID: 1726204
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro brodimoprim activity on nosocomial bacterial strains.
    Nicoletti P; Novelli A; Periti P
    J Chemother; 1993 Dec; 5(6):430-4. PubMed ID: 8195834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
    Thabaut A; Meyran M; Fabre R; Dellamonica P; Moreau N
    Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antibacterial spectrum of trimethoprim and brodimoprim.
    Amyes SG
    J Chemother; 1993 Dec; 5(6):417-21. PubMed ID: 8195832
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.